eMedicine Specialties > Radiology > Brain/Spine
Brain, Multiple Sclerosis: Follow-up
Updated: Jan 24, 2007
Intervention
No radiologic interventions are applicable in patients with MS, with the exception of the occasional fluoroscopic-guided lumbar puncture to obtain CSF for oligoclonal banding assessment.
More on Brain, Multiple Sclerosis |
| Overview: Brain, Multiple Sclerosis |
| Imaging: Brain, Multiple Sclerosis |
Follow-up: Brain, Multiple Sclerosis |
| Multimedia: Brain, Multiple Sclerosis |
| References |
| « Previous Page | Next Page » |
References
Anderson DW, Ellenberg JH, Leventhal CM, et al. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol. Mar 1992;31(3):333-6. [Medline].
Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med. Apr 1990;14(1):154-9. [Medline].
Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. Nov 1997;120(Pt 11):2059-69. [Medline].
Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med. Dec 9 1993;329(24):1764-9. [Medline].
Berg D, Maurer M, Warmuth-Metz M, et al. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol. Sep 2000;57(9):1289-92. [Medline].
De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol. Jan 2001;58(1):65-70. [Medline].
Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. Dec 1988;38(12):1822-5. [Medline].
Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology. Jul 1991;180(1):215-21. [Medline].
Hashemi RH, Bradley WG Jr, Chen DY, et al. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology. Aug 1995;196(2):505-10. [Medline].
Hauser SL. Multiple sclerosis and other demyelinating diseases. In: Fauci AS, Braunwald E, et al, eds. Harrison's Principles of Internal Medicine. 13th ed. McGraw-Hill;1994:2287-95.
Koldewijn EL, Hommes OR, Lemmens WA, et al. Relationship between lower urinary tract abnormalities and disease- related parameters in multiple sclerosis. J Urol. Jul 1995;154(1):169-73. [Medline].
Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. Mar 1999;161(3):743-57. [Medline].
Lukes SA, Crooks LE, Aminoff MJ, et al. Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol. Jun 1983;13(6):592-601. [Medline].
McDonald WI, Compston A, Edan G. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. Jul 2001;50(1):121-7. [Medline].
McDonald WI, Compston A, Edan G. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-7.
McDonald WI, Compston A, Edan G. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. Jul 2001;50(1):121-7. [Medline].
Morrissey SP, Miller DH, Kendall BE, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain. Feb 1993;116 (Pt 1):135-46. [Medline].
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. Sep 28 2000;343(13):938-52. [Medline].
O''Riordan JI, Thompson AJ, Kingsley DP, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. Mar 1998;121(Pt 3):495-503. [Medline].
Ormerod IE, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. Dec 1987;110(Pt 6):1579-616. [Medline].
Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. Feb 1988;38(2):180-5. [Medline].
Poser A. New Diagnostic Criteria For Multiple Sclerosis; Guidelines For Research Protocols. Ann Neurol. 1983;13:227-31.
Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. Mar 1983;13(3):227-31. [Medline].
Rao SM, Leo GJ, Bernardin L. Cognitive dysfunction in multiple sclerosis, I: frequency, patterns, and prediction. Neurology. May 1991;41(5):685-91. [Medline].
Rizzo JF 3rd, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology. Feb 1988;38(2):185-90. [Medline].
Robertson WD, Li D, Mayo J. Magnetic resonance imaging in the diagnosis of multiple sclerosis. J Neurol. 1985;232(Suppl 1):58.
Sandberg-Wollheim M, Bynke H, Cronqvist S, et al. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. Apr 1990;27(4):386-93. [Medline].
Schumacher GA, Beebe G, Kibler RF. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552-68.
Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol. Apr 2000;21(4):702-6. [Medline].
Further Reading
Keywords
MS, brain lesions, MS lesions, brain plaques, MS plaques, autoimmune disease, cognitive impairment, neurologic deficit, relapsing-remitting MS, chronic-progressive MS, inactive MS, clinically definite multiple sclerosis, CDMS
Follow-up: Brain, Multiple Sclerosis